Divis laboratories ipo. Read more on Divis Lab.
Divis laboratories ipo. But investors are further enthused by Nov 29, 2024 · International brokerage Citi reiterated its bullishness over Divi's Laboratories by naming it as its top pick in the Indian pharma sector, driven by the drugmaker's expanding pipeline for its The company's growth trajectory took a major leap in 2004 when it went public with an Initial Public Offering (IPO). Find company research, competitor information, contact details & financial data for DIVI'S LABORATORIES LIMITED of Hyderabad, Telangana. Established in 1990, we are engaged in the manufacturing of leading generic APIs, Nutraceutical Ingredients and custom synthesis of APIs and Intermediates Aug 29, 2025 · See 9 recent research reports for DIVISLAB, BSE:532488 Divi's Laboratories Ltd. 2B in Feb 19, 2025 · Here is a brief summary of the brokerage firm’s analysis of the above-mentioned CRDMO companies: Divi’s Laboratories: Outperform | Target price: Rs 7,400 | Upside potential: 26. com. Jul 16, 2014 · Explore News Stock Market LIVE Updates Stock to Watch Today Stocks To Buy Today CUET UG Result 2025 Crizac IPO Gold and Silver Rate Today Latest News LIVE Jane Street Ban Delhi CM Bungalow Renovation Upcoming IPO 2025 Aug 29, 2024 · Divis Laboratories | Buy | Target Price: Rs 5,250 | Stop Loss: Rs 4,850 After correcting from its high, Divi's Labs is now forming higher highs and higher lows on the daily chart, signaling the Divis Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. May 23, 2022 DR. Sep 9, 2025 · Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve unaudited financial results for the quarter ended June 30, 2025. 94, Earnings per share 77. Stay updated with Divis Laboratories Share Price today! Get the latest Divi's Laboratories Ltd (DIVISLAB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The brokerage has given a target price of Rs 7,150 apiece, which implied 16. If you had invested ₹10,000 in 2003, in 22 years, it would have grown to ₹9. Get all the information on Divis Labs with historic price charts for NSE / BSE. from 6 source (s) with an average share price target of 6414. Nov 15, 2024 · Stay updated with the latest stock market news and live updates. Divi's Laboratories IPO - Read Divi's Laboratories IPO Review and Analysis on The Economic Times. 32, Volume: 241519, Price-to-earnings ratio 81. Research Divi's Laboratories' (NSEI:DIVISLAB) fundamentals, past performance, valuation, dividends and more. to 'buy' rating, citing promising growth trajectory driven by its involvement in the production of anti-diabetes drug tirzepatide, other peptides, and contrast media. Jul 1, 2025 · divis laboratories shares Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Address: 1-72/23 (P)/DIVIS/303, Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana, India – 500 032. 00 Crores year on year, a rise of 8. Brokerages highlight the Divi's Lab Q4 2024 results today: Divi's Laboratories, the pharmaceutical giant, delivers a mixed bag of consolidated estimates performed by ET NOW as it rounds up the fiscal year with its Q4FY24 results. Use the PitchBook Platform to explore the full profile. 1, Market capitalization: 156204. 2) The company has commissioned ~50% of a Rs. 34 (1) Annual Report. Established in 1990, we are engaged in the manufacturing of leading generic APIs, Nutraceutical Ingredients and custom synthesis of APIs and Mar 31, 2025 · Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. 8 crore up 12. Total Expenses for Q4FY25 of ₹1,807. divislabs. Sep 19, 2025 · Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. Financial Results: Divis Laboratories reported Total revenue for Q4FY25 of ₹ 2,671 Crore up from ₹2,382 Crore in Q4FY24, a rise of 12% y-o-y. 37 per cent. The company reported its Jul 21, 2023 · A complete timeline of Divis Laboratories World’s largest API manufacturing facility's History from founding to present including key milestones and major events. 00 Crores up from ₹2,303. presents the Incorporation Date, Public Issue Date, Book Closure dates, Face Value, Key Listing information, Indices it is a part of, and the Exchanges where the company is listed. View All US Drug Master Files (DMF, DMFs) filed by Divis Laboratories with the FDA on PharmaCompass. 36 per cent at Rs 6,205 per share on the BSE in the intraday trade of Tuesday. L. 2. Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Our liveblog combines fundamental and technical Sep 20, 2023 · As on 20-09-2023 Company Description: Divi’s Laboratories is a leading pharmaceutical company headquartered in India, recognized for its excellence in research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and custom synthesis solutions. Sep 17, 2025 · Divi's Laboratories Ltd. Feb 4, 2025 · Stock Market Today: Divi's Laboratories share price gained more than 5% in the morning trades on Tuesday, a day after it reported its earnings for the third quarter (Q3) of the financial year 2024-25. May 23, 2025 · Deven Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 7518 in its research report dated May 23, 2025. Check stock performance, fundamentals, market cap, shareholding 2 days ago · Divis Labs Share Price – Live NSE/BSE price, PE ratio, EPS, market cap, financial reports & corporate announcements, only on ET Markets. Check issue date, price, lot size, and more to make informed investment decisions today! May 25, 2024 · Divi's Laboratories Q4 Results: Divi's Laboratories announced its January-March quarter results for fiscal 2023-24 (Q4FY24) on Saturday, May 25, reporting a rise of 67. Dec 24, 2024 · Divis Lab: GLP-1 opportunity to unfold in the medium term Global sales from these drugs in Q3 CY2024 were a staggering $11. 79, Volume: 722958, Price-to-earnings ratio 76. Jul 8, 2025 · HSBC Global Research has upgraded Divi's Laboratories Ltd. May 16, 2025 · Future and Options Divis Laboratories: View the real-time Divis Laboratories Future share price and assess historical data, charts, technical analysis and the share chat forum. Nov 9, 2020 · Big Pharma continues to expand global sourcing, and this has given a great push to the Divi’s Laboratories Ltd stock. 5 days ago · Divis Laboratories Latest News - Stay updated with DIVISLAB news headlines, market movements, corporate actions, earnings, results, IPO news and more. Oct 6, 2023 · Learn here at Moneysukh what is DRHP in IPO, how to read and difference between DRHP and RHP or from where download the DRHP and RHP documents. Aug 27, 2020 · Planning on buying Divi's Laboratory shares? Click here for information on Divi's Laboratory including about the company, important milestones, share price, balance sheet & more. The firm's net profit reached ₹430 crore 4 hours ago · Multiple people shot at Mormon church in Michigan, shooter dead Jan 2, 2025 · Divi’s Laboratories Ltd. 05, Market capitalization: 152831. 27%. Find out Divi's Laboratories IPO Issue Price, Subscription Dates and Status, Divi's Laboratories IPO Listing Date and more. Aug 8, 2024 · Stay updated with the Divi's Laboratories Stock Liveblog, your one-stop destination for real-time information and analysis of a leading stock. Jun 3, 2023 · Read this case study of Divi's Laboratories vs Dr. 07% amid high volume The stock's current performance, coupled with recent financial data and corporate actions, provides a comprehensive view of Divis DIVIS LABORATORIES | 52 036 sledujících uživatelů na LinkedIn. presents the key annual result items, its comparison with the sector peers and its Annual Results for the last five years. Are you looking for Divi'S Laboratories Limited financials? Visit Tofler for its net worth, ratios, profit and loss, competition, products, industry, and financial analysis. Check issue date, price, lot size, and more to make informed investment decisions today! Sep 19, 2025 · Get the latest Divi's Laboratories Limited (NSE:DIVISLAB) stock price with financials, statistics, dividends, charts and more. on Thursday said it has started commercial operations at Kakinada plant in Andhra Pradesh. Keep track of Divis Labs with the latest details, including: Last traded price 5884. said the U. DIVIS LABORATORIES | 54,423 followers on LinkedIn. 12) each in its Hong Kong initial public offering, according to two We would like to show you a description here but the site won’t allow us. While, Divis Laboratories Ltd. Consolidated net profit for the company rose 64. DIVIS LABORATORIES | 54,659 followers on LinkedIn. Nov 10, 2017 · Divis Laboratories announced that the Company has been informed by the US-FDA that the Agency has completed evaluation of the Company's corrective actions in response to FDA's Warning Letter: 320-17-34 dated 13 April 2017. com Oct 11, 2024 · Stock Check: This week, Divi's Laboratories share price has garnered attention following Citi Research's initiation of a ‘buy’ rating on the stock, setting a target price of ₹ 6,400. Get the latest details on Divis Labs, including: Last traded price 5763. 8 per share on BSE. It provides active pharmaceutical ingredients (APIs), registered starting materials, and intermediates to more than 100 countries across the world. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended December 31 2024 Divi's Laboratories is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), serving as a reliable partner for major pharmaceutical companies worldwide. stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund & stock research house. 8% Stake Oswal Pumps IPO – RHP Updates & Thoughts on Peer Comp and Valuation Lucror Analytics – Morning Views Asia Divi’s Laboratories (DIVI IN): Double-Digit Growth and Margin Improvement to Continue Feb 5, 2025 · Motilal Oswal recommended Neutral rating on Divis Laboratories with a target price of Rs 6200 in its research report dated February 03, 2025. Nov 5, 2024 · Shares of Divi's Laboratories Ltd. Watch videos, top stories and articles on Divis Laboratories at moneycontrol. 00 Crores up from ₹1,669. Sep 20, 2017 · Divi’s Laboratories Ltd. NS) stock quote, history, news and other vital information to help you with your stock trading and investing. "L Kishore Babu, Chief Financial Officer of the company May 18, 2024 · If Divis laboratories outperformed then it's probable replacement by Bharat electronics by 25% or so very soon and maintains that outperformance till the end of July, only then it could be saved. Jan 9, 2024 · 2003: Initial Public Offering (IPO) and listing on stock exchanges BSE, NSE, and HSE. The firm’s shares have almost doubled in the past one year, compared with the gains of Explore smart investing in India with FinanceShastra. Aug 3, 2024 · Divis Laboratories, a leading pharmaceutical company, has reported a 21% year-on-year (YoY) increase in its net profit for the first quarter of FY25. You can view the entire list of company locations such as Registered Office, Branch Office, Head Office, Corporate Office, Regional Offices, Overseas Office, Factory, Plants, and Training Centers etc. 26, Earnings per share 69 Apr 18, 2025 · Divi's Laboratories Ltd. 6 per cent in net profit at Aug 25, 2025 · Divi's Labs Shares: Jefferies upgraded Divi's Laboratories Ltd. The company is engaged in the manufacture of Active Pharmaceutical ingredients, intermediates and nutraceutical 5 days ago · DIVISLAB Share Price Today - Get Divis Laboratories Ltd Live NSE/BSE stock price with Market Cap, Performance, Fundamentals, Share holding, Resistance/Support, Financials, News & Events. Divi's Laboratories is initiating coverage with a HOLD rating and 12-month target price of 756. Explore the latest updates on Divi's Laboratories stock, including: Last traded price 4834. The operations are a part of the Phase I of Unit 3 greenfield project at Ontimamidi Village (Kona) in Thondangi Mandal, Kakinada. Get live BSE share price, latest news, announcements, financial results and compare with peer companies for Divis Laboratories Ltd. Jul 14, 2017 · Divis Laboratories will hold a meeting of the Board of Directors of the Company on 22 July 2017, to consider and approve un-audited financial results for the quarter ended 30th June 2017. divis lab share analysis,divis lab share price,divis lab share latest news,divis lab share,divis lab share news,divis lab share target,divis lab share news t Nov 8, 2021 · Stocks in Focus on November 8: Paytm IPO, Divi's Laboratories, IndusInd Bank, Sun Pharma, CDSL to Tata Motors and many more The stock markets kicked off Samvat 2078 on a positive note on Thursday, November 4, 2021, with the benchmark indices gaining during the ceremonial one-hour-long Muhurat trading session. 90. Aug 27, 2024 · Some buzzing stocks including Trent Ltd, Divis Laboratories Ltd and Bharat Heavy Electricals Ltd (BHEL) are likely to remain under the spotlight of traders for the session today. Overview Edit Overview Section Organization Name Divi's Laboratories Announced DateNov 7, 2022 Funding TypePost-IPO Equity Money Raised obfuscated obfuscated Pre-Money Valuation₹895. Oct 25, 2024 · Divis-Laboratories-Initiating-Coverage-15062020 - Free download as PDF File (. Find the latest Divi's Laboratories Limited (DIVISLAB. 3 days ago · What's Divis Laboratories Ltd share price today. With a commitment to innovation and sustainability, Divi’s has diversified its product portfolio to include Contrast Media Jun 26, 2025 · Divis Labs Futures - Future trading, future and options, Intraday, future market, technical chart, Divis Labs financial report details on Moneycontrol. As per data available on BSE, total traded quantity on the counter stood at 6,459 shares with a turnover of Rs 3. 37, Volume: 1299208, Price-to-earnings ratio 85. 31, 2024, according to its exchange filing on Monday. DIVI – MANAGING DIRECTOR, DIVI’S LABORATORIES LIMITED MS. Check the Divi's Laboratories Ltd. 9% quarter-on-quarter). MURALI K. m. Stay updated with the Divi's Laboratories Stock Liveblog, your one-stop destination for real-time information and analysis of a leading stock. 10 at 01:39PM hours (IST) on Tuesday. 1200 crore capex plan in FY20 Jul 19, 2020 · After allegations of insider trading, Divi's Laboratories chief financial officer (CFO) L Kishore Babu has gone on leave for three months. Motaparti administers all aspects of Material Sourcing and Procurement, Corporate Finance and Investor Relations. 63 per cent to Rs 5740. May 19, 2025 · During the quarter, generic business pricing and volumes remained stable, and Divis's expects launch of new products to support growth. with details for Divi's Laboratories Ltd. May 23, 2024 · Nilima Prasad Divi, daughter of Murali Divi, the founder of Indian pharma MNC Divi’s Laboratories, has bought two properties in Hyderabad's posh Jubilee Hills for Rs 80 crore, documents from 6 days ago · Divis Laboratories Ltd Share Price Today: Get the live NSE/BSE Stock Price of Divis Laboratories Ltd with performance, market cap, financial report, and company profile at India Infoline. Feb 4, 2025 · Shares of Divi's Laboratories extended their previous day's gains and gained up to 5. 08, Earnings per share 69. The analyst projects sales to grow at a CAGR of 21% to 1922 crore by FY13 driven by growth in generic APIs Jan 14, 2021 · The differentiated and niche business model of Divi’s Laboratories Ltd has caught investors’ fancy. Reddy’s Jul 14, 2025 · Divis Laboratories share price falls more than 4% in early trade, partially recovers With the stock currently trading at Rs 6,642. Book a demo today. 60 per share on the BSE after beating street estimates in its second quarter earnings for the financial year 2024-25 (Q2FY25) With five years of experience, expertise and a proven track-record of helping many companies with its turn-key and consulting strengths, Divis Laboratories established its first manufacturing facility in 1995. Divi’s Laboratories is an Indian pharmaceutical company headquartered in Hyderabad. The target price has been raised to Rs 7,900 from Rs 5,020, reflecting a 14. It showcases the company's efforts in environmental sustainability, including reducing carbon footprint, conserving energy and water, and managing waste. - Rediff MoneyWiz, the personal finance service from Rediff. Feb 3, 2025 · Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues Divi's Laboratories share price surged 5. NILIMA PRASAD DIVI – WHOLE-TIME DIRECTOR, (COMMERCIAL), DIVI’S LABORATORIES LIMITED MR. Share Price today. Find the Divis Laboratories Ltd IPO details with IIFL Capital. Milestones: 1990 -Divis Research Center (DRC) established. [11] The company went public with its initial public offering (IPO) on 17 February 2003. Jun 17, 2024 · DIVI'S LABORATORIES is a 35 year old company with registered office in Ranga Reddy, Telangana. 2 days ago · Divi's Laboratories Limited Share Price Today, Live NSE Stock Price: Get the latest Divi's Laboratories Limited news, company updates, quotes, financial reports, 52 week high low, tips, historical charts, market performance etc at NSE India. 8% Divi's Labs is the largest CDMO firm in India and works with a majority of top 20 global innovator-pharma companies on small molecule products. 31st Annual Report 2020-21 Annual Report Subsidiary Financials AGM Notice Email sent to shareholders – AGM Notice & Annual Report Sep 11, 2025 · Mutual Fund Share Holding and Fund action in Divis Laboratories: Explore list of mutual funds that have invested in Divis Laboratories & analyse the ownership details to gain insights. Should you buy Divi's laboratories' shares? Here's what InCred Equities recommend. 1B Divi's Lab Share price in 2003 was ₹64. That compares with the Rs 500-crore consensus estimate of analysts tracked by Bloomberg. Divi's Laboratories Ltd. 3 days ago · Current and historical market capitalization for Divi's Laboratories Limited (NSE:DIVISLAB) stock, including annual, quarterly and daily history with a chart and statistics. to Buy as it expects that the growth momentum will continue as custom synthesis segment and new launches will support. stock price live with fundamentals, technicals, company profile, news & events. Explore the latest updates on Divi's Laboratories stock, including: Last traded price 5077. EPS (TTM) Earnings Per Share (Trailing Twelve Months) Formula = Net Profit attributable to Equity Shareholders (TTM) / No. 59, Volume: 1003530, Price-to-earnings ratio 73. Dive into its business model, financials, SWOT analysis & growth prospects. Nov 10, 2024 · Divi's Laboratories witnessed a 46. Sep 27, 2017 · Ashwani Gujral of ashwanigujral. After a few years, the organization opened a research center in Hyderabad in 2010. The generic segment accounted for 49% of Q4 revenue. 5 on 29 August 2025 - Get Divis Laboratories Ltd latest news live updates on BSE/NSE along with the Divis Lab stock summary, today’s high and low, market cap, P/E ratio, fundamentals, performance, share holding pattern, financial report, profit & loss statement and more on ET Now. About Divi's Laboratories Limited Divi’s has been established for more than 29 years in Hyderabad, India with two manufacturing units and is among the top pharmaceuticals companies in India. DIVIs LABORATORIES LTD. Read more on Divis Lab. Our liveblog combines fundamental and technical 2 days ago · Divi's Laboratories share price - Track Divi's Laboratories Ltd. [13] [12] In 2010, the company established a research centre in Hyderabad. 6% surge in profit, reaching Rs. M. com told CNBC-TV18, " Divis Laboratories is a clear short. This growth was driven by increased demand from new and existing customers seeking supply chain diversification beyond China. Get all latest & breaking news on Divis Laboratories. 0, Market capitalization: 152989. 2 days ago · Discover detailed historical data, explore the Divi's Labs share price history over various time intervals to track performance trends. Aug 25, 2025 · Divis Laboratories shares rise 2. Apr 1, 2023 · Go back to company Divis Laboratories Limited 2023-2024 Sustainability Report The report highlights Divi's commitment to sustainable chemistry and responsible growth. 2007 was the year when Divis Laboratories ventured into Nutraceuticals business as it opened the doors of a new Nutraceuticals 6 days ago · Company profile for Divi's Laboratories Limited (NSE:DIVISLAB) with a description, list of executives, contact details and other key facts. About Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Sep 19, 2025 · Here's the live share price of Divi's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information. 06. 00. Jun 2, 2023 · This comprehensive live blog update provides real-time insights and analysis of the share price performance of Divis Laboratories, a renowned pharmaceutical company. 67, Earnings per share 63. Divis Lab Share Price, 6131. In the year-ago quarter, the company had logged a net profit of ₹321 crore. of Equity Shares PE Price Earnings Formula = Last Traded Price / EPS (TTM) PB Price to Book Value Formula Jun 13, 2025 · In today’s briefing: Sai Life Sciences IPO Lockup – US$840m Lockup Release; TPG Asia up 5. Chances are people are trapped on the long side and today you will get follow through because the shorts May 18, 2025 · Divi’s Laboratories reports 23% net profit growth in Q4 FY25, highlights expansion in CDMO, peptides, and contrast media, with ₹1,400 Cr capex ahead. The company went public with its initial public offering (IPO) on 17 February 2003. 5% year-on-year (down 29. Aug 5, 2016 · Divis Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2016, to consider and approve, the un-audited financial results for the first quarter ended 30 June 2016 (Q1). Apr 21, 2025 · Shares of Divi's Laboratories Ltd rallied almost 5% on 21 April after the company announced signing a supply agreement with a multinational pharmaceutical company. Get the latest business insights from Dun & Bradstreet. Divis Laboratories Limited Feb 21, 2025 · Stock market today: Shares of pharma major Divi's Laboratories on Friday, February 21, witnessed a near 4% decline after SBI Mutual Fund pared its stake in the company. 7: MARKET TREND OF DIVIS LAB Divis Research Center (Divis Laboratories Ltd) starting as a Research Center and focused on developing new process for the production of Active Pharma Ingredients and Intermediates in India, reported its financial results for the quarter ended 30 JUNE, 2013. In 2003, Divis Laboratories launched its Initial Public Offer (IPO). Divis Labs Options Get stock options, options trading tips, call options, nifty options, Divis Labs options strategies, option chain details on Moneycontrol. [12][10] In 2010, the company established a research centre in Hyderabad. 51, while the price-to-book Akums Drugs IPO GMP, Price, Date, Allotment Anurag Gupta -July 24, 2024 0 Jul 14, 2025 · DIVIS LABORATORIES LTD - Reg. on Friday said it has inked a supply agreement with a global pharmaceuticals firm. reported that US customers are actively seeking alternatives to China, indicating a promising future regardless of the Act’s final form. 11 percent to Rs 6281. of Equity Shares CEPS (TTM) Cash Earnings Per Share (Trailing Twelve Months) Formula = Net profit attributable to Equity Shareholders (TTM) + Depreciation (TTM) /No. The stock has gained 85% this year. The journey continued with accolades, certifications, and expansions, solidifying Divis Laboratories’ position as a trailblazer in the pharmaceutical sector. 32 Lakh by 2025. The stock was in demand after the company posted healthy Q4 results and recommended dividend. In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam. With rising global demand for generic and specialty drugs, Divi’s Lab is expected to benefit significantly. 10 f1. 2 days ago · Dr Reddy's Laboratories Share Price - Get Dr Reddys Laboratories Ltd Live NSE/BSE Share Price & historical returns, Performance, Financials, Market Cap, Analysts Rating, Target Price, Latest News and Insights to invest online with INDmoney. Sep 10, 2024 · Neuland Labs Ltd. Dec 10, 1990 · The Listing Page of Divi's Laboratories Ltd. 4 per cent at Rs 6145. 1-72/23 (P)/DIVIS/303, Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana, India – 500 032. KISHORE BABU – CHIEF FINANCIAL OFFICER, DIVI’S LABORATORIES LIMITED MR. ” Divis lab came out with its IPO in the year 2003 at a rate of 140 rupees per share and achieved success over the years. Mumbai: Divis Laboratories ’ export shipment for the month of March 2023 is expected to be around $92 million as against the previous 11-month average of $55-60 million, analysts privy to the data have told ET NOW. com equips the user with tools and information in the form of graphs, charts, expert advice, and more to stay up-to-date and make informed decisions. 1994 -Divis Research Center changes its name to Divis Laboratories Limited to reflect its growing area of operations and its plans to enter the 2 days ago · Divis Laboratories Share Price Today 26 Sep 2025: Track Divis Laboratories share price today on NSE/BSE with real-time updates. Learn how a commitment to quality and integrity drives its business agenda. May 18, 2025 · What are Divis Laboratories Ltd quarterly results? Divis Laboratories Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance. divis lab share analysis,divis lab share price,divis lab share latest news,divis lab share,divis lab share news,divis lab share target,divis lab share news t Stay updated with the latest stock market news and live updates. stock price live NSE/BSE with stock fundamentals, market cap, financial report, annual report, balance sheet, profit & loss, news, company profile, forecast, and historic returns. Jul 8, 2022 · The brokerage house expects Divis Laboratories to report net profit at Rs 626. 71 crore till 01:39PM (IST). May 19, 2025 · From a technical standpoint, SEBI-registered analyst Thoviti Brahmachary highlights that Divis Laboratories is currently trading near a key pivot level on the weekly chart, with the Relative Strength Index (RSI) indicating a shift in momentum. Our liveblog combines fundamental and technical insights to provide a Mar 9, 2020 · Divi's Laboratories on Monday (9 March) said DCV-SEZ unit at Visakhapatnam started commercial production from 9 March 2020. Striving for leadership through chemistry | Divi’s Laboratories Limited is one of the largest API companies in the world, with ~$1. Sep 24, 2024 · Explore the fundamental analysis of Divi's Laboratories Ltd, including its financial results, stock performance, peer comparison, and investment insights. 5, Market capitalization: 128340. May 24, 2024 · Divi's Laboratories' consolidated net profit in the quarter ended March 2024 jumped 68% year-on-year (YoY) to ₹538 crore, as per the financial results declared by the Hyderabad-based pharmaceutical major on Saturday, May 25. 15, Market capitalization: 149197. Stay updated with the latest stock market news and live updates. open and close date, listing date, price band, IPO lot size, allotment, subscription status, review, key insights, and much more only at Business Standard Mar 12, 2003 · Open Instant Account Now! Why Divi’s? Copyright © 2025, Divi's Laboratories Limited. May 19, 2025 · Divi's Labs share price: Shares of pharmaceutical company Divi's Laboratories gained 5 per cent and logged an all time high on Monday, May 19, 2025, at ₹6596. ’s third-quarter profit increased, beating estimates. DIVIS LABORATORIES | 54,515 followers on LinkedIn. Established in 1990, we are engaged in the manufacturing of leading generic APIs, Nutraceutical Ingredients and custom synthesis of APIs and Intermediates DIVIS LABORATORIES LTD - Intimation Of Appointment Of Secretarial Auditor - Rediff MoneyWiz, the personal finance service from Rediff. Nov 7, 2022 · Learn more about DIVIS LABORATORIES's company details, contact information, competitors, and more. DIVIS LABORATORIES LTD - Announcement under Regulation 30 (LODR)-Newspaper Publication - Rediff MoneyWiz, the personal finance service from Rediff. , the drug manufacturer surged to the highest point of the trading session on Monday, February 3, after the company reported its December quarter results. 2 billion. Established in Hyderabad, India, over 30 years ago, Divi’s Laboratories operates three state-of-the-art manufacturing facilities and is recognised as one of India’s leading pharmaceutical companies. It is well positioned to benefit from the recovery in the global CRAMS industry. Aug 16, 2025 · Stay updated with the latest stock market news and live updates. This strong focus has positioned Divi's among the top three API Nov 10, 2024 · Divi's Labs set for continued growth, valuation may cap upside: Analysts Shares of Divis's Laboratories scaled up to 3. Stay on top of the game with our comprehensive coverage, featuring the latest details on Divis Labs stock, including: Last traded price 5620. . Mar 9, 2020 · Divi's Laboratories begins commercial production at Visakhapatnam unit Divi's Laboratories, established in Hyderabad, is a pharmaceutical company with two manufacturing units. 07Aug Divis Laboratories informs about press Divis Laboratories has informed that it enclosed copies of the newspaper. Aug 10, 2020 · Divi's Laboratories Ltd has become the second most valuable listed pharmaceutical company with its share price rising 65% so far in 2020, beating drugmakers like Aurobindo Pharma, Dr. com DIVIS LABORATORIES | LinkedIn 팔로워 51,568명 | Striving for leadership through chemistry | Divi’s Laboratories Limited is one of the largest API companies in the world, with ~$1. The focus is on the trading day of June 2, 2023, offering readers a real-time perspective on the factors influencing the stock's movement and an understanding of the broader market dynamics impacting the pharmaceutical sector. Her father is the founder of Divi Laboratories and also the richest man in the Telugu states. 6 days ago · Read about Divis Laboratories Ltd company details like share price, management, news and more at IIFL Capital. 2B in revenue and exporting to more than 100 countries. All Rights Reserved. 86. drug regulator completed inspection of the company’s Unit-2 in Visakhapatnam. Forbes India describes her father as an “Accidental Chemist. 18% upside from Friday's close. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30 2024 Feb 4, 2025 · Shares of Divis Laboratories Ltd climbed 5 per cent in Tuesday's trade after the drugmaker's Q3 results beat the consensus on all fronts with revenue, Ebitda and profit after tax ahead by 3 per www. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical Ingredients (API) make it a preferred pick in the pharma sector. COM. The company operates on the core principle of creating value for all stakeholders through sustainable leadership in chemistry and high-quality production. Find accurate contact data easily with LeadIQ. 24%. See the company profile for Divi's Laboratories Limited (DIVISLAB. 00, Divis Laboratories' stock movement reflects the early market Aug 22, 2025 · Divis Laboratories shares surge 2. Feel free to Add NDTV Profit as trusted source on Google. 36 per cent at the day's high in Tuesday's session to Rs 6,205 per share on the BSE. Feb 3, 2025 · Divi’s Laboratories Ltd. Get a comprehensive understanding of Divis Labs with our coverage of 3 days ago · Get Divis Laboratories share price, market statistics, corporate action, fundamental and technical analysis at Upstox. Established in 1990, we are engaged in the manufacturing of leading generic APIs, Nutraceutical Ingredients and custom synthesis of APIs and Intermediates Subsidiaries Divis Laboratories (USA) Inc; New Jersey, USA Divi’s Laboratories Europe AG, Basel, Switzerland Registered Office Divi Towers, 1-72/23(P)/DIVIS/303 Cyber Hills, Gachibowli, Hyderabad - 500032 CIN: L24110TG1990PLC011854 Phone: +91 40 66966300 Fax: +91 40 66966460 E-mail: mail@divislabs. 16. The Company have been issued a form 483 with 5 observations and these shall be responded within the time permitted Sep 25, 2022 · China electric vehicle maker Zhejiang Leapmotor Technology is set to raise $800 million by pricing its shares at HK$48 ($6. NS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key May 23, 2025 · DIVIS LABORATORIES LTD - Announcement under Regulation 30 (LODR)-Earnings Call Transcript - Rediff MoneyWiz, the personal finance service from Rediff. 2 days ago · DIVISLAB Stocks Price - Know every detail about Divi's Laboratories Ltd. Divis Laboratories was successfully listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), marking a new phase in its corporate journey. 50 in early trade. Get Divis Laboratories Ltd latest news on BSE/NSE stock price live updates, Divis Laboratories Ltd financial results and overview, Divis Laboratories Ltd stock price history, statistics overview, Divis Laboratories Ltd stock week and yearly details, Divis Laboratories Ltd share price returns and much more only on Business Standard Nov 15, 2024 · Gain valuable insights of Divi's Laboratories share. 1) Divi's Laboratories is a leading manufacturer of Active Pharmaceutical Ingredients (API) and nutraceutical ingredients, deriving ~88% of revenues from exports to over 95 countries. Reddy Labs to compare them over their core differences, profitability ratios, total revenue, and products and services. Divis Laboratories view the listing information and the key dates of the various companies including the exchanges on which the company is listed. Overall Divi's expects to grow double digit going forward and the capex at Kakinada should support the growth Aug 22, 2025 · With the stock currently trading at Rs 6,156, Divis Laboratories showcases a notable increase in early trade, amid very bearish market sentiment and recent financial developments. May 2, 2025 · Divi's Laboratories Limited Share Price Today, Live NSE Stock Price: Get the latest Divi's Laboratories Limited news, company updates, quotes, financial reports, 52 week high low, tips, historical charts, market performance etc at NSE India. Read this stock analysis to know why investing in this stock can provide you valuable returns. Discover DiviS Laboratories Mission, Vision, and Core Values for 2025. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard. 4% upside potential. Aug 21, 2024 · Divis Lab: Read Divis Lab Latest News also find Videos, Photos and information about Divis Lab from ZeeBiz. The unit is currently Divis Laboratories Ltd Share Price today - Get latest Performance analysis and chart, shareholding pattern, technical analysis, financial and annual report at Motilal Oswal Sep 17, 2024 · Divi’s Laboratories: a leading Indian pharma firm excelling in API production. Web site created using create-react-appDun & Bradstreet helps companies large and small drive growth, manage risk, and strengthen the performance of their business. 7, Volume: 233513, Price-to-earnings ratio 80. Oct 11, 2022 · On February 17, 2003, Divi's Labs went public with an initial public offering (IPO). 8x with a 24. 00 Crore year on year, a rise of 12. Earlier in the day, the stock saw a gap up start to the session. divis laboratories shares Blogs, Comments and Archive News on Economictimes. The company is a leading player in the CRAMS space engaged in manufacturing generic APIs and custom synthesis. Jul 7, 2025 · Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q4FY25 of ₹2,585. May 23, 2022 · Information on stock, financials, earnings, subsidiaries, investors, and executives for Divi's Laboratories. The stock traded at a price-to-earnings (P/E) multiple of 90. Nov 2, 2017 · Divis Laboratories on Thursday said it was informed by the US FDA that it will be lifting the Import Alert 66-40 and moving to close out the warning letter issued to the company at Unit-II in Dec 7, 2016 · Divis Laboratories announced that the Company's Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US-FDA from 29 November 2016 to 06 December 2016. It was founded in 1990 and is based in Hyderabad, India. com Her father is the founder of Divi Laboratories and also the richest man in the Telugu states. SATISH CHOUDHURY – COMPANY SECRETARY Divis Lab Share Price - Get Divis Laboratories Live BSE/NSE stock price with latest research reports, balance sheet, stock analysis and share price history at Angel One. pdf), Text File (. VENKATESA PERUMALLU – GENERAL MANAGER, FINANCE & ACCOUNTS, DIVI’S LABORATORIES LIMITED MR. 2 days ago · Get Divi's Laboratories Ltd. 11%, among top gainers on Nifty Next 50 Shares of Divis Laboratories moved up by 2. Divi's Lab Share Price Target 2024: Divi's Laboratories reported a profit after tax of Rs 538 crore in Q4 FY24 and also announced a dividend payout of 1500 per cent on face value Rs 2 each. (DIVISLAB) live share price today on NSE/BSE at 3:31 p. along its Announcement Dates, Ex-Split Dates, Old Face Value New Face Value. Feb 3, 2025 · Shares of Divis Laboratories Ltd. Divis Laboratories Share Price - Get live BSE/NSE Divis Laboratories share price with latest research reports, balance sheet, stock analysis & more at ICICI Direct. 35, Earnings per share 63. Annual Reports: Review of financial performance, strategy, and achievements. In two sessions post the company's Q3 earnings, the stock has climbed as much as 10. 02, Earnings per share 77. on Sep 19, 2025 is Rs 6200. Dec 1, 2020 · Divis Laboratories announced the commencement of construction of Divi`s Laboratories Unit-III Facility (the Project) at Kona Forest, Ontimamidi Village, Thondangi Mandal, Near Kakinada, East Godavari District, Andhra Pradesh from the 7 December 2020. The Yearly Results page of Divi's Laboratories Ltd. Sep 19, 2025 · Divi's Laboratories Ltd. Create real-time notifications to follow any changes in the live stock price. is seeing a notable increase in opportunities, particularly for products in phases 2 and 3, driven by the passage of the Biosecure Act. Stay updated with Divis Laboratories Share Price today! Divis Laboratories Ltd Peer Comparison: Get Details Divis Laboratories Ltd competitors analysis on its Market Price, PE and PB Ratio, Market Cap, 52 weeks high and low at Kotak Securities. 54, Volume: 537669, Price-to-earnings ratio 74. Over 2 days ago · Divi’s Laboratories mission is to create products and services that enhance the health and well-being of our customers by focusing on safety, quality, and innovation. Divi's Laboratories Competitors List - Compare Divi's Laboratories with its Competitors in terms of Share Price, Stock price forecast, trends, charts and more on The Economic Times DIVIS LABORATORIES | 63,716 followers on LinkedIn. In 2007, the pharma company set up a Nutraceuticals facility at its Manufacturing Unit 2, near Vishakhapatnam. com Statutory Auditors You can view the Split history of Divi's Laboratories Ltd. Street estimates for GLP 1 drugs sales for anti-diabetic and May 19, 2025 · Company Overview: Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients. Explore financials, technicals, Deals, Corporate actions and more. com Website: www. Explore the latest details on Divis Labs, including: Last traded price 5757. [1] Jan 29, 2025 · Welcome to the Divis Labs Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent stocks in the market. [11] Feb 17, 2003 · Divi's Laboratories Ltd IPO 2003 - Get Divi's Lab. Under the long-term agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties, Divi's Laboratories said in a regulatory filing. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. S. 24 Key Management Personnel (KMPs) have been associated with the company since its inception. Our comprehensive coverage combines fundamental and technical View today's Divi's Laboratories Ltd. Learn more! Jan 9, 2017 · Divis Laboratories announced that its has filed its detailed response to the 'Form 483' observations of the US-FDA for the Company's unit at Visakhapatnam within the time permitted. DIVISLAB share price today: Divi's Laboratories stock price live with performance, financial statements, peer comparison, & latest news. Established in 1990, we are engaged in the manufacturing of leading generic APIs, Nutraceutical Ingredients and custom synthesis of APIs and Intermediates Sep 10, 2025 · Geojit Financial Services recommended reduce rating on Divis Laboratories with a target price of Rs 5400 in its research report dated September 10, 2025. performance, financials, technical, shareholding, risk ratios & corporate actions. Ranked among the top 3 API manufacturers globally, Divi’s also stands at the forefront of sustainable chemistry. 05, Market capitalization: 134710. Start investing in DIVISLAB today! Feb 3, 2025 · Discover the Divis Labs Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. stock price and latest DIVI news and analysis. 2 days ago · Divis' Laboratories Share Price - Get Divis Laboratories Ltd Live NSE/BSE Share Price & historical returns, Performance, Financials, Market Cap, Analysts Rating, Target Price, Latest News and Insights to invest online with INDmoney. asker. Apr 3, 2025 · Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a leading stock. Company History - Divi's Laboratories Ltd. 510 crores in Q2FY25, fueled by robust growth in their custom synthesis business. Nov 12, 2024 · Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 6812 in its research report dated November 11, 2024. Get insights on Nifty 50 stocks, market trends, and personalized strategies to grow your wealth. txt) or view presentation slides online. 2 days ago · Divis Labs Share Price: Find the latest news on Divis Labs Stock Price. info@divislabs. com +91 (40) 6696 6300 Quick Links About Us Milestones Business Operations Business Segments Careers Customers Divi’s manufactures Generic APIs, Intermediates, and Nutraceutical Ingredients, and offers Custom Synthesis of APIs to Big Pharma, providing a competitive advantage throughout the entire product lifecycle. You can view name of Chairman, CEO, CFO, Management Team, Board of Directors and Key Executives of Divi's Laboratories Ltd. This came after the pharma company delivered robust third quarter results Feb 21, 2025 · Stay up-to-date with the Divis Labs Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent stock. MY STORY Nilima Motaparti is the director onboard commercial at Divis Laboratories Ltd, a pharmaceutical company headquartered in Hyderabad. 1991-1993 -DRC successfully develops several commercial processes for intermediates and bulk actives and supplies to manufacturing majors. Experts & Broker view also get the Divis Jan 1, 2003 · Divi's Laboratories primarily serves the pharmaceutical, nutritional, food and beverage, and feed industries with its range of products. 5% year-on-year to Rs 589 crore in the three months through Dec. Forbes India describes her father as an Jan 30, 2018 · Drug maker Divis Laboratories may take a call on shifting its proposed factory to an alternate site in the next 1-2 two quarters, the company said at its recent analyst call. zota as6 bwknj nteanc h4spz krk1t tbn3 fykn8fg hkyy vbyel